Sector portfolio · VC firm · United States

SVB Capital's Biotech portfolio

SVB Capital has backed 41 Biotech startups in rounds we track, $3.6B between them, shown by the stage each has reached. The best-funded is Puma Biotechnology.

41startups backed
6stages
$3.6Braised between them
Stage not reportedbiggest stage

SVB Capital's whole portfolioSVB Capital's profile

Stage not reported

15

Series C and later

12

Series B

6

Series A

4

Pre-seed and seed

2

Growth

2

Segment by segment

Stage not reported

15 startups · $1.3B raised

  1. Puma BiotechnologyPuma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.United States$427M
  2. Intuity MedicalIntuity Medical develops blood glucose monitoring systems for diabetes management.United States$275M
  3. HLS TherapeuticsHLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.Canada$221M
  4. Assurex HealthAssurex Health is a personalized medicine company founded in 2006, specializing in pharmacogenomics.United States$105M
  5. DrFirstDrFirst provides software solutions for physicians and healthcare providers ranging from HIPAA secure messaging, e-prescribing, and EHR.United States$68M
  6. PPPatara PharmaPatara Pharma operates in the healthcare industry focusing on the biotechnology business.United States$44M
  7. Oxford BioTherapeuticsOxford BioTherapeutics (OBT) is a clinical-stage oncology company focused on developing innovative cancer treatments through targeUnited Kingdom$37M
  8. CODA BiotherapeuticsCODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.United States$28M

Series C and later

12 startups · $1.4B raised

  1. CVRxCVRx is a medical device company developing implantable technology for the treatment of high blood pressure.United States$369M
  2. Unchained LabsUnchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it.United States$193M
  3. aTyr PharmaaTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on United States$181M
  4. Click TherapeuticsClick Therapeutics delivers safe and effective digital treatments to patients in need.United States$149M
  5. BBioVexTHOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquisUnited Kingdom$133M
  6. SingulexSingulex develops direct molecular detection technology, cardiovascular monitoring, and related solutions to understand and manage diseases.United States$127M
  7. ENDOTRONIXEndotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.United States$119M
  8. PPhaseBioUnited States$50M

Series B

6 startups · $406M raised

  1. scPharmaceuticalsScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.United States$187M
  2. US HealthVestUS HealthVest is a behavioral healthcare firm that helps the development of psychiatric hospitals.United States$141M
  3. Sense.lySensely is a software developer and chatbot-based platform designed to assist insurance plan members and patients.United States$27M
  4. Elysium HealthElysium Health is a New York-based manufacturer of dietary supplements and consumer health products, focused on translating scientUnited States$25M
  5. Neuromod DevicesNeuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.Ireland$17M
  6. TridiuumTridiuum is a digital health company that is advancing the treatment of behavioral health conditions.United States$9.5M

Series A

4 startups · $107M raised

  1. Miach OrthopaedicsMiach Orthopaedics is a medical device company that designs technologies intended to facilitate new tissue growth.United States$37M
  2. drchronoThe essential platform for modern medical practices to make care more informed, more interactive, and more personalized.United States$28M
  3. TranscripticTranscriptic is a robotic cloud laboratory for life science.United States$28M
  4. Troy MedicareTroy Medicare is arming independent pharmacies with a health plan and platform tailored to their most vulnerable patients.United States$15M

Pre-seed and seed

2 startups · $65M raised

  1. Eupraxia PharmaceuticalsEupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.Canada$64M
  2. EEpiBiomeA precision microbiome engineering company developing alternatives to small-molecule antibiotics for use in agriculture and human health.United States$1.1M

Growth

2 startups · $327M raised

  1. Epic SciencesEpic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.United States$165M
  2. CardioFocusCardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.United States$162M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names SVB Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioSVB Capital's Fintech portfolio38 startups · $4.9BSector portfolioSVB Capital's AI portfolio23 startups · $1.7BSector portfolioSVB Capital's Advertising & Adtech portfolio22 startups · $1.2BSector portfolioSVB Capital's IT Services portfolio22 startups · $1.7BSector portfolioSVB Capital's Big Data & Analytics portfolio20 startups · $836MSector portfolioSVB Capital's Software portfolio16 startups · $1.5B

Raising from investors like SVB Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps